Last reviewed · How we verify
NCT07266662
Comparative Effects of Sensory Augmentation and Neuromodulation on Enhancing Motor Recovery Among Stroke Survivors
NA trial testing Sensory Augmentation in Stroke (CVA) or Transient Ischemic Attack in 36 participants. Currently enrolling.
25 May 2026
Quick facts
| Lead sponsor | Lahore University of Biological and Applied Sciences |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 25 November 2025 |
| Primary completion | 25 May 2026 |
| Estimated completion | 30 May 2026 |
| Sites | 2 locations across Pakistan |
Drugs / interventions tested
- Sensory Augmentation
- Neuromodulation
- Combination of Sensory Augmentation and Neuromodulation
Conditions studied
- Stroke (CVA) or Transient Ischemic Attack — all drugs for Stroke (CVA) or Transient Ischemic Attack →
Sponsor
Lahore University of Biological and Applied Sciences
Who can join
Adults 45 to 56, any sex, with Stroke (CVA) or Transient Ischemic Attack. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effectiveness of two rehabilitation techniques-Sensory Augmentation (using mirror therapy) and Neuromodulation (using transcranial direct current stimulation, tDCS)-in improving motor recovery among stroke survivors. Stroke often results in long-term impairments, particularly in upper limb motor function, which is critical for daily activities. Although current rehabilitation strategies help, more effective solutions are needed to enhance recovery. Participants, aged 45-65 with chronic stroke and upper extremity impairments, will be randomized into three groups: Group 1 will receive a combination of sensory augmentation (mirror therapy) and neuromodulation (tDCS) with routine physical therapy; Group 2 will receive sensory augmentation (mirror therapy) with routine physical therapy; and Group 3 will receive neuromodulation (tDCS) with routine physical therapy. The interventions will take place four times a week for 8 weeks, and participants will undergo motor function assessments, including the Fugl-Meyer Assessment and Jebsen-Taylor Test, before and after the intervention. The study will compare the effects of each intervention on motor recovery, specifically focusing on upper limb function and motor control. The findings could lead to improved rehabilitation protocols, offering stroke survivors better therapeutic options and enhancing their quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07266662
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sensory Augmentation
Trials testing the same drug.
- NCT03988400 — Sensory Augmentation Methods in Stroke · EARLY_PHASE1 · completed
Other recruiting trials for Stroke (CVA) or Transient Ischemic Attack
Currently open trials in the same condition.
- NCT07319312 — Evaluating the Effect of Nurse-Led Stroke Transitional Care in Tanzania · recruiting
- NCT07113041 — Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke · NA · recruiting
- NCT05780905 — Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes · Phase 4 · recruiting
Other Lahore University of Biological and Applied Sciences trials
Trials by the same sponsor.
- NCT07529093 — Combined Effects of Mulligan's Mobilization With Movement and Kinetic Control Training on Pain, Range of Motion, Gait an · NA · not yet recruiting
- NCT07474818 — Loaded and Task Specific Training in Spastic Diaplegic CP to Improve Gait and Functional Mobility. · NA · not yet recruiting
- NCT07401706 — Effects of Vestibular Rehabilitation and Routine Physical Therapy in Athletes With Post Concussion Syndrome · NA · not yet recruiting
- NCT07425197 — Comparative Effects of Two Rehabilitation Approaches on Lumbopelvic Function in Sacroiliac Joint Dysfunction · NA · not yet recruiting
- NCT07460011 — Effects of Pain Neuroscience Education on Pain, Kinesiophobia in Patients With Non Specific Low Back Pain · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07266662 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lahore University of Biological and Applied Sciences
- Last refreshed: 17 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07266662.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing